Stability of drug additives in peritoneal dialysis solutions in a new container

Peritoneal Dialysis International

Volumn 24, Issue 6, 2004, Pages 590-595

  Voges, Markus ^a,b   Faict, Dirk ^a   Lechien, Guy ^a   Taminne, Michel ^a  

^a Baxter R and D Europe   (Belgium)

^b NONE   (Belgium)

Author keywords

Amino acid; Bicarbonate; Cefazolin; Drug stability; Gentamicin; Glucose; Glucose polymer; Heparin; Lactate; Netilmycin; PD solutions; Peritonitis; Tobramycin; Vancomycin

Indexed keywords

CEFAZOLIN; DIANEAL; DRUG ADDITIVE; EXTRANEAL; GENTAMICIN; HEPARIN; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; NETILMICIN; NUTRINEAL; PERITONEAL DIALYSIS FLUID; PHYSIONEAL; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANALYTIC METHOD; ARTICLE; BIOASSAY; CONCENTRATION RESPONSE; CONTAINER; CONTROLLED STUDY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TEMPERATURE MEASUREMENT;

EID: 9544257278     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080402400619     Document Type: Article

References (16)

1. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20: 828-9]. Perit Dial Int 2000; 20:396-411.
2. Pawlaczyk K, Kuzlan-Pawlaczyk M, Anderstam B, Heimburger O, Bergstrom J, Waniewski J, et al. Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis. Nephrol Dial Transplant 2001; 16:669-71.
3. Bailie GR, Kane MP. Stability of drug additives to peritoneal dialysate. Perit Dial Int 1995; 15:328-35.
4. Dooley DP, Tyler JR, Wortham WG, Harrison LS, Starnes WF Jr, Collins GR, et al. Prolonged stability of antimicrobial activity in peritoneal dialysis solutions. Perit Dial Int 2003; 23:58-62.
5. Lin YF, Wu CC, Lin SH, Wang DP, Wang CN. Stability of cefazolin sodium in icodextrin-containing peritoneal dialysis solution. Am J Health Syst Pharm 2002; 59: 2362-4.
6. Wu CC, Wang DP, Wong CY, Lin YF. Stability of cefazolin in heparinized and nonheparinized peritoneal dialysis solutions. Am J Health Syst Pharm 2002; 59: 1537-8.
7. Stamatakis MK, Leader WG, Tracy TS. Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions. Am J Health Syst Pharm 1999; 56: 246-8.
8. Microbiological Assay of Antibiotics. In: European Pharmacopoeia. 4th ed. Strasbourg, France: Council of Europe; 2001: General chapter 2.7.2.
9. Antibiotics - Microbial Assay. In: United States Pharmacopeia. Rockville, USA: United States Pharmacopeial Convention, Inc; 2000: General chapter 81. USP 24, NF 19.
10. Assay of Heparin. In: European Pharmacopoeia. 4th ed. Strasbourg, France: Council of Europe; 2001: General chapter 2.7.5.
11. Trissel LA. Handbook on Injectable Drugs. 11th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2000.
12. Wideröe TE, Smeby LC, Berg KJ, Jörstad S, Svartas TM. Intraperitoneal (125 J) insulin adsorption during intermittent and continuous peritoneal dialysis. Kidney Int 1983; 23:22-8.
13. Williams P, Marriott J, Coles GA, Stead R, Tranæus A, Hopwood AM, et al. Insulin efficacy with a new bicarbonate/lactate peritoneal dialysis solution. Perit Dial Int 2000; 20:467-9.
14. Quellhorst E. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. J Am Soc Nephrol 2002; 13(Suppl 1):S92-6.
15. Choo C, Martis L, Faict D, Wilmet I, Zdarsky D, Rainosek A, et al. Compatibidity of vancomycin, gentamicin, tobramycin, heparin and insulin with Physioneal® [Abstract]. Perit Dial Int 1998; 18:110.
16. Choo C, Kunzler J, Murphy G, Scheithe J, Titus A, Zdarsky D. Compatibility of Extraneal® with gentamicin, vancomycin, heparin, and insulin [Abstract]. Perit Dial Int 1998; 18:110.